About us Contacts Interactions: 118 620
Drug search by name

Sodium polystyrene sulfonate Rectal and Obstructive bowel disease

Result of checking the interaction of drug Sodium polystyrene sulfonate Rectal and disease Obstructive bowel disease for safety when used together.

Check result:
Sodium polystyrene sulfonate Rectal <> Obstructive bowel disease
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of sodium polystyrene sulfonate is contraindicated in patients with obstructive bowel disease. Cases of intestinal necrosis, which may be fatal, and other serious gastrointestinal adverse events (bleeding, ischemic colitis, perforation) have been reported in association with sodium polystyrene sulfonate use. Therapy with this agent should be avoided in patients who have not had a bowel movement post-surgery, and patients who are at risk of developing constipation or impaction. Therapy with sodium polystyrene sulfonate should be discontinued in patients who develop constipation during treatment.

Sodium polystyrene sulfonate Rectal

Generic Name: sodium polystyrene sulfonate

Brand Name: Kalexate, Kayexalate, Kionex

Synonyms: Sodium polystyrene sulfonate (Rectal)

Interaction with food and lifestyle